Welcome to Our Medtech Talk Podcast Channel
Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.
In this episode of Medtech Talk, host Geoff Pardo speaks with Michael Jaff, DO, chief medical officer and vice president of Clinical Affairs, Technology, and Innovation at Boston Scientific. Dr. Jaff has a long list of achievements and a robust background as a professor of Medicine at Harvard Medical School, president of Newton-Wellesley Hospital, medical director at the Massachusetts General Hospital, and more. Dr. Jaff shares his thoughts on good leadership, medical device innovation (and how they can help hospitals succeed), and how hospitals and manufacturers can navigate post-COVID-19 financial strains. He also discusses his journey from clinician to hospital CEO to the manufacturing industry, as well as Boston Scientific’s outlook on the future.
Special thanks to Silicon Valley Bank for sponsoring this episode.
Michael R. Jaff, DO, is the chief medical officer and vice president of Clinical Affairs, Technology, and Innovation at Boston Scientific. He is a retired professor of Medicine at Harvard Medical School, where he was also the president of Newton-Wellesley Hospital. Before that, he was the inaugural Paul & Phyllis Fireman endowed chair in Vascular Medicine and medical director at the Massachusetts General Hospital. He founded VasCore, the Vascular Ultrasound Core Laboratory, which has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries. He is the first physician to receive the designation as Master of the Society for Vascular Medicine.
